Investigating gene therapy challenges for hemophilia A
Molecular Virology Core
This study is looking at ways to make gene therapy for hemophilia A work better by figuring out what challenges come up with the treatment, so that patients can have safer and more effective options in the future.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11023046 on NIH RePORTER |
What this research studies
This research focuses on understanding the factors that hinder effective gene therapy for hemophilia A, particularly through the use of adeno-associated viral (AAV) vectors. The team will explore issues related to the production and design of these vectors, the expression of factor VIII, and the immune system's role in therapy outcomes. By developing new assays to analyze vector properties and impurities, the research aims to enhance the safety and efficacy of gene transfer methods. Patients may benefit from improved gene therapy techniques that could lead to better treatment options for hemophilia A.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hemophilia A who may benefit from advanced gene therapy treatments.
Not a fit: Patients with other types of hemophilia or those who do not have a genetic basis for their condition may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective gene therapies for patients with hemophilia A.
How similar studies have performed: Previous research has shown promise in improving gene therapy techniques, but this specific approach to AAV vector analysis is relatively novel.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Xiao, Weidong — Indiana University Indianapolis
- Study coordinator: Xiao, Weidong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.